OMEGA HEALTHCARE INVESTORS INC 8K

Omega Healthcare Investors reported strong Q1 2026 results, increased its full-year AFFO guidance midpoint, executed significant new investments and asset sales, and detailed its balance sheet, dividend, and updated 2026 outlook.

Omega Healthcare Investors, Inc. reported strong financial and operating results for the first quarter of 2026, highlighted by higher net income and AFFO versus Q1 2025, $251 million of new investments across U.S., U.K., and Canadian assets (including a 9.9% equity stake in Saber and new DIP financing to bankrupt operator Genesis), and active portfolio management through $34.5 million of asset sales and a planned $480 million strategic disposition of 18 CommuniCare facilities. The company also raised the midpoint of its full-year 2026 Adjusted FFO guidance to $3.22 per diluted share, completed an additional $75 million of real estate acquisitions in April 2026, and maintained a quarterly dividend of $0.67 per share while ending the quarter with $4.5 billion of debt and $1.6 billion of undrawn revolver capacity. Management noted continued favorable operating trends and strong coverage metrics, while cautioning that results remain sensitive to operator performance, regulatory changes, interest rates, foreign exchange, and execution on planned dispositions, loan repayments, and investment redeployment.

Filing Facts

CIK

888491

Ticker

-

Form

8K

Source Type

sec

Accession

0000888491-26-000016

Alert Tier

7